Objective: ICU telemedicine is a novel approach for providing critical care services from a distance. We sought to study the extent of use and patterns of adoption of this technology in U.S. ICUs. Design: Retrospective study combining a systematic listing of ICU telemedicine installations with hospital characteristic data from the Centers for Medicare and Medicaid Services. We examined adoption over time and compared hospital characteristics between facilities that have adopted ICU telemedicine and those that have not. Setting: U.S. ICUs. Setting: U.S. hospitals from 2002 to 2010. Interventions: None. Measurements and Main Results: The number of hospitals using ICU telemedicine increased from 16 (0.4% of total) to 213 (4.6% of total) between 2003 and 2010. The number of ICU beds covered by telemedicine increased from 598 (0.9% of total) to 5,799 (7.9% of total). The average annual rate of ICU bed coverage growth was 101% per year in the first four study years but slowed to 8.1% per year over the last four study years (p < 0.001 for difference in linear trend). Compared with non-adopting hospitals, hospitals adopting ICU telemedicine were more likely to be large (percentage with > 400 beds: 11.1% vs 3.7%, p < 0.001), teaching (percentage with resident coverage: 31.4% vs 21.9%, p = 0.003), and urban (percentage located in metropolitan statistical areas with more than 1 million residents: 45.3% vs 30.1%, p < 0.001). Conclusions: ICU telemedicine adoption was initially rapid but recently slowed. Efforts are needed to uncover the barriers to future growth, particularly regarding the optimal strategy for using this technology most effectively and efficiently. (Crit Care Med 2014; 42:362-368) Key Words: critical care; intensive care units; rural hospitals; telemedicine I CU telemedicine uses audiovisual technology to provide critical care services from a remote location (1, 2) . In its most common form, ICU telemedicine consists of remote monitoring of ICU patients using fixed installations, either continuously or during nighttime hours (3) . Telemedicine can potentially improve ICU outcomes by increasing access to the expertise of dedicated intensivist physicians (4), facilitating early recognition of physiological deterioration (5) , and prompting bedside providers to implement routine evidencebased practices (6) . Yet studies evaluating the effect of telemedicine on ICU outcomes show mixed results, with some studies showing significant improvements in mortality and others showing no benefit (7) . In addition, there are major organizational barriers to the broad adoption of ICU telemedicine, including the high technological and staffing costs, as well as a lack of consensus about how and where it is best applied (8) .
Given these tensions, we sought to understand the patterns of ICU telemedicine adoption and implementation in the United States. In particular, we examined both the pace of adoption and the degree to which telemedicine has been preferentially adopted in small, rural hospitals where it may have the greatest potential to improve outcomes (9) (10) (11) . Although ICU telemedicine was first described in the 1970s (12) , modern applications were not introduced until 2000 and meaningful adoption did not begin until 2003 (13) . Beginning in that year we linked information on ICU telemedicine use (14) to publically available hospital-level data from the Centers for Medicare and Medicaid Services (CMS), examining the rate of ICU telemedicine adoption, the geographic distribution of existing installations, and the hospital characteristics associated with adoption.
METHODS

Data Sources
Information on ICU telemedicine adoption was obtained from a report by the New England Health Care Institute (NEHI) and the Massachusetts Technology Collaborative in December 2010 (14) . As part of this report, NEHI developed a comprehensive list of all ICU telemedicine installations in the United States. The goal of this list was an enumeration of all ICUs covered by telemedicine. Central hubs, from which the monitoring was performed, were not included unless that facility also had covered ICU beds. This list also did not list ICU telemedicine installations that involved only periodic consultation or robotic telepresence-although this type of telemedicine is increasing in use, the extent of its adoption in the ICU setting is unknown (15) .
To obtain the list, NEHI convened a working group of representatives from critical care professional societies, manufacturers of commercial ICU telemedicine systems, and early adopting health systems with knowledge of current use. Working group members created the initial list of known installations. NEHI staff mapped this list to the American Hospital Association Annual Survey, and then contacted each program to determine the number and location of hospitals with ICUs covered by telemedicine as well as the calendar year in which each program began. Content experts in ICU telemedicine and hospital organization reviewed the list for accuracy and completeness. The final list contained 46 telemedicine programs at 249 hospitals.
Information on U.S. hospitals was obtained from the CMS. We used two CMS data sources: the Healthcare Cost Reporting Information System (HCRIS) and the Medicare Provider Analysis and Review (MedPAR) file. HCRIS is a hospital-level data file containing basic characteristics on all nonfederal U.S. hospitals, including street address, ownership status, and bed counts. MedPAR is a patient-level data file containing the final action claims of all fee-for-service Medicare beneficiaries. We limited the analysis to only general acute care hospitals and critical access hospitals, as identified in HCRIS.
We linked the hospitals in the NEHI report to hospitals in the CMS data by hospital name, city and state, and year. We linked hospitals through 2010, the year in which the NEHI report ended and the most recent year of CMS data available. Hospitals were linked only when they had ICU beds covered by telemedicine, and not if they only served as the originating site (i.e., the "hub"). In cases when a hospital could not be matched exactly by name, city, and state, we contacted the hospital to determine its identification in the CMS data files. From the NEHI list, we excluded two programs in the Veterans Affairs Health System because hospitals in these programs are not present in CMS data.
Variables
We used HCRIS and MedPAR to derive hospital-level variables along two domains: structural characteristics (e.g., measures of size, location, and teaching status) and technological capacity (i.e., measures of overall capacity to care for ICU patients). Structural characteristics were obtained directly from HCRIS. These included hospital size (< 100 beds, 100-400 beds, or > 400 beds) (16); number of ICU beds; ownership (nonprofit, for profit, or government, i.e., hospitals owned by a municipality, county, state, or other governmental institution); teaching status by resident-to-bed ratio (nonteaching: ratio = 0, small teaching: ratio > 0 and < 0.25, large teaching ≥ 0.25) (17); U.S. Census region by state (Northwest, Midwest, South, or West); and urban/rural status by metropolitan statistical area classification of the hospital's ZIP code (nonmetropolitan, or metropolitan with a population of < 100,000, 100,000-1 million, or > 1 million). We also calculated regional ICU competition using the Herfindahl-Hirschman Index, an econometric measure of market competition equal to the sums of squares of market share within regions (18) . We defined regions using Dartmouth Atlas Hospital Referral Regions (HRRs) and calculated market share based on the number of ICU beds per hospital divided by the number of total ICU beds in each hospital's HRR (19) .
Technological capacity variables were obtained from MedPAR by first identifying fee-for-service Medicare beneficiaries at each hospital receiving 11 procedures using validated International Classification of Diseases, version 9, Clinical Modification, procedure codes. We focused on procedures that either represented a scarce technological resource or are commonly associated with admission to an ICU, including neurosurgery, cerebral arteriogram, MRI, peripheral arteriovenogram, liver transplant, heart or lung transplant, bone marrow transplant, esophageal cancer resection, lung cancer resection, coronary artery bypass graft surgery, and percutaneous transluminal coronary angioplasty (20) (21) (22) . To avoid misspecification due to miscoding, we only considered a hospital to provide that service if at least 10 patients in that hospital received a procedure-specific code in a calendar year.
Analysis
To examine temporal trends in ICU telemedicine adoption, for each study year, we calculated the number of hospitals using ICU telemedicine and the number of ICU beds in hospitals covered by telemedicine, both as absolute counts and as proportion of the total. For the ICU beds analysis, we made the assumption that hospitals using ICU telemedicine had all their ICU beds covered. We used Poisson regression to test the statistical significance of observed linear trends. To examine the geographic distribution of hospitals adopting telemedicine, we created year-specific density maps based on the proportion of ICU beds within the HRR covered by telemedicine with superimposed markers indicating the exact location of each adopting hospital (23) . For this analysis, we selected three years (2003, 2006 To examine hospital characteristics and procedural utilization according to telemedicine status, we compared each variable across groups using 2006 data, representing the midpoint of the study period. We used t tests, chi-square tests, Fisher exact tests, and Wilcoxon rank-sum tests to test the statistical significance of observed differences, as appropriate. We performed two comparisons. First, we compared hospitals that have adopted telemedicine during the study period with those that have not. Second, among facilities adopting telemedicine, we compared hospitals that adopted telemedicine early in the study period (2003) (2004) (2005) (2006) with those that adopted telemedicine late in the study period (2007) (2008) (2009) (2010) , based on the study midpoint.
Data management and statistical analyses were performed using Stata version 11.0 (StataCorp, College Station, TX). Geographic analyses were performed using ArcGIS (ESRI, Redlands, CA). This research was reviewed and approved by the University of Pittsburgh Institutional Review Board.
RESULTS
A total of 4,760 hospitals were open at any time during the study period and were included in the final analysis. Of these, five hospitals had already adopted ICU telemedicine by 2003 (the actual year of adoption was 2000) and an additional 218 adopted ICU telemedicine at some point from 2003 to 2010, for a total of 223 adopting hospitals. Ten hospitals withdrew the technology during the study period. Overall the number of U.S. hospitals with ICU telemedicine increased from 16 (0.4%) in 2003 to 213 (4.6%) in 2010 (p < 0.001 for temporal trend), for an average annual increase of 61.0% per year (Fig. 1A) .
However, most of that growth occurred during the first 4 years of the study period (average annual rate of growth: 132.3% per year) compared with the last 4 years (average annual rate of growth: 8.4% per year) (p < 0.001 for difference in growth rate between time periods).
The overall number of ICU beds covered by telemedicine increased from 598 (0.4%) in 2003 to 5,799 (7.9%) in 2010 (p < 0.001 for temporal trend), for an average annual growth rate of 48.0% per year (Fig. 1B) . Most of that growth occurred during the first 4 years of the study period (average annual rate of growth: 101.1% per year) compared with the last 4 years (average annual rate of growth: 8.1% per year) (p < 0.001 for difference in growth rate between time periods). The geospatial distribution of ICU telemedicine coverage over time is shown in Figure 2 . Of 306 HRRs in the United States, 3 (1.0%) had a hospital with telemedicine in 2003, increasing to 204 (66.7%) in 2009. Initial adoption was located on the East and West coasts although over time there was no clear regional predominance.
Hospital characteristics associated with ICU telemedicine adoption are shown in Table 1 . Compared with hospitals without ICU telemedicine, hospitals with ICU telemedicine were more likely to be large, nonprofit, teaching hospitals located in large metropolitan statistical areas. Conversely, hospitals that did not adopt telemedicine were more likely to be small, for profit, nonteaching hospitals in rural areas. There were no differences in the regional ICU competition index between adopters and nonadopters. Hospitals without telemedicine were less well resourced with regard to major technologies and procedures.
Hospital characteristics associated with early (2003-2006) versus late (2007-2010) adoption are shown in Table 2 . Generally, hospitals in both groups were similar although later adopters were more likely to be smaller than early adopters.
DISCUSSION
Using a systematic accounting of ICU telemedicine in the United States linked to federal data, we found a substantial expansion of ICU telemedicine from 2003 to 2010. This increase was most rapid immediately following the introduction of commercial programs in 2000 and the publication of an early study demonstrating significant mortality reductions and cost savings associated with the technology (13) . However, the rate of increase slowed in more recent years, with few new installations in the latter part of the study period.
One way to interpret the slowing growth of ICU telemedicine is to infer that the technology has reached the saturation point, consistent with the classic Rogers model of diffusion of innovation (24) . Under this model, the growth of ICU telemedicine is expected to plateau as late adopters and laggards adopted the technology, and further expansion would be unlikely. This pattern would suggest that the existing barriers to further diffusion are quite substantial, limiting ICU telemedicine's potential applicability at less than 10% of all ICU beds. An alternative model might be the "tipping point" concept, in which an innovation is adopted at a linear rate until novel contextual factors drive additional rapid adoption (25) . Under this model, additional expansion may yet occur if current barriers are reduced and more compelling data create a clear sense of perceived usefulness among relevant decision makers.
Our study underscores the fact that that there are substantial barriers to telemedicine adoption that must be addressed prior to further adoption. The primary barrier is costs-the cost of a telemedicine program exceeds $3 million annually and is not easily borne by hospitals that are already observing declines in revenue (26) . Some experts have posited that these expenditures may be regained by reductions in ICU length of stay and prevention of ICU-acquired complications (13) . However, these positive effects are not assured, and the true cost savings associated with reductions in ICU length of stay may not be large enough to meaningfully affect a hospital's bottom line (27) . Another source of cost recovery would be for physicians to bill for telemedicine services. Although physician reimbursement for telemedicine services is increasingly common (28, 29) , few payers currently reimburse for critical care services provided via telemedicine, given the importance of bedside assessment in the ICU as well as concerns about overutilization and a resultant devaluation of critical care services (30) .
Another key barrier is the perception of telemedicine on the part of bedside practitioners, especially nurses who may be doubtful of the potential benefits and concerned about disruptions in daily workflow associated with remote monitoring (31) . Lastly, there are reasonable questions of efficacy given the low quality of the literature and the number of negative studies (7) . In support of this notion are several studies calling into question the benefits of nighttime intensivist staffing (32, 33) . These studies suggest that routine processes of care are more important than nighttime staffing by bedside or remote providers.
We found that a minority of adopting hospitals were small (i.e., < 100 beds) and rural (i.e., located in a nonmetropolitan area). These findings suggest that ICU telemedicine is only partly fulfilling its promise as strategy to extend the benefits of intensivist physicians to patients in small, rural hospitals. Currently, the vast majority of hospitals in the United States do not have trained intensivist physicians (9) . Although telemedicine has great potential to improve the quality of critical care in these hospitals, it appears that a substantial proportion of adoption is occurring in large, urban hospitals that are already well resourced. It is possible that small, rural hospitals are finding other approaches to dealing with severely ill patients, such as through transfers to higher levels of care or quality improvement cooperatives (34) . It is also possible that, contrary to intuition, large, urban hospitals are the most appropriate hospital types for ICU telemedicine. This might be true if telemedicine improves outcomes at hospitals with extremely high acuity, even in the setting of high-quality bedside care.
These adoption patterns may also be a reflection of the varying reasons that hospitals adopt ICU telemedicine. In particular, there are two ways that ICU telemedicine can enter a healthcare market: through the initial introduction of a telemedicine "hub" and through the subsequent addition of new "spokes" onto an existing hub. It may be that these different forms of adoption have different barriers and facilitators. For example, initial introduction of a hub may be the result of an academic medical center's desire to invest in new infrastructure and community outreach, regardless of return on investment. Conversely, subsequent expansion into spoke hospitals may depend more strongly on local conditions, with adoption predicated on the availability of a hub site and potential return on investment playing a larger role. Thus, it may be that although we observed preferential adoption in large, urban hospitals, this adoption is only a necessary precedent to more rapid adoption in small rural hospitals. Indeed, we show that later adopting hospitals are generally smaller than early adopting hospitals, suggesting that future growth may come by expanding the reach of existing hubs rather than the creation of new hubs. Additional research is needed to best define the ideal use of this potentially transformative technology. As noted in a recent federally sponsored consensus conference on the research agenda in critical care telemedicine, the key questions are not whether this technology should be applied, but where and how it can be applied most effectively and efficiently (35) . Research is needed to determine the settings in which telemedicine technology is most effective and the organizational factors that are associated with its success and failure. For example, studies could compare the effectiveness of telemedicine programs in ICUs with varying case-mix and multidisciplinary staffing patterns. Without this research we risk investing in monitoring technology that, like previous monitoring technologies in the ICU such as the pulmonary artery catheter, fails to improve care on average and is ultimately abandoned (36) .
Our study has several limitations. First, although we used the most comprehensive listing of existing telemedicine programs to date, it is possible that this list was incomplete. However, NEHI took several major steps to ensure the accuracy and completeness of their listing. Second, because we based our analysis on the NEHI report, we only included ICU telemedicine programs that consisted of comprehensive remote monitoring. Periodic consultation via robotic telepresence, as is sometimes used in the emergency department or neurocritical care setting, was not included in our analysis (37) . We suspect that the issues surrounding adoption of robotic telemedicine models differ substantially from the issues surrounding continuous remote monitoring, warranting a separate study. Third, our study only includes programs through 2010, the most recent year of complete CMS data. It is possible that adoption trends have changed since that time. It is also possible that the adoption trends we observed were influenced by the overall U.S. economy, which entered recession in 2009, and thus are reflective of healthcare growth as a whole rather than issues specific to ICU telemedicine. Fourth, we assumed that hospitals using telemedicine use it in all their ICU beds and that ICU beds associated with a command center came live when the command center came live. These assumptions may not be true, particularly in large hospitals with multiple ICUs. Thus, we may have slightly overestimated the extent of ICU telemedicine adoption in the United States or attributed some adoption to earlier than it actually occurred. However, given the limited overall adoption we observed, the extent of this error is likely minor.
CONCLUSIONS
Future effectiveness research and future technological innovations that reduce its cost may change the adoption patterns of ICU telemedicine we observed, facilitating its adoption in more hospitals and more small, rural facilities. Until then, we demonstrate that the adoption of this innovative approach to critical care delivery appears to have slowed.
